Asston Pharmaceuticals Approves Auditor Appointment and Key Executive Remuneration Hikes
Asston Pharmaceuticals Ltd 路 Change in Auditor 路 01 Oct 2026, 7:32 pm
Asston Pharmaceuticals Approves Auditor Appointment and Key Executive Remuneration Hikes At its 7th Annual General Meeting on 29th Sep'26, Asston Pharmaceuticals Limited secured shareholder approval to adopt FY26 audited standalone financial statements and re-appoint Managing Director Ashish Narayan Sakalkar, retiring by rotation. Members approved the appointment of M/s Panchal S K & Associates as Statutory Auditors. Additionally, shareholders sanctioned remuneration increases for Managing Director Ashish Narayan Sakalkar, Whole-time Director and CEO Saili Jayaram More, and Non-Executive Director Sachin Chandrakant Badakh.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Unaudited Financial Results for the Half Year ended 30 September, 2026 with Limited Review Report. 路 12 Nov 2026
- Outcome of the Board Meeting 路 12 Nov 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... 路 12 Nov 2026
- Change in registered office address 路 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. 路 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached 路 06 Oct 2026
- Change in Management 路 01 Oct 2026
- Scrutinizer Report 路 01 Oct 2026
